These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12727953)

  • 1. Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study.
    Zitzmann M; Depenbusch M; Gromoll J; Nieschlag E
    J Clin Endocrinol Metab; 2003 May; 88(5):2049-54. PubMed ID: 12727953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.
    Zitzmann M; Nieschlag E
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3844-53. PubMed ID: 17635942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of
    Firouzi V; Borjian Boroujeni P; Rokhsat Talab Z; Mohammadi M; Sadighi Gilani MA; Sabbaghian M; Mohseni Meybodi A
    Syst Biol Reprod Med; 2019 Aug; 65(4):326-332. PubMed ID: 31030566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of testosterone replacement therapy.
    Zitzmann M
    Pharmacogenomics; 2009 Aug; 10(8):1341-9. PubMed ID: 19663677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.
    Zitzmann M
    Nat Clin Pract Urol; 2007 Mar; 4(3):161-6. PubMed ID: 17347661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular reactivity in hypogonadal men is reduced by androgen substitution.
    Zitzmann M; Brune M; Nieschlag E
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5030-7. PubMed ID: 12414868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of serum testosterone levels and androgen receptor CAG repeat polymorphism on the risk of erectile dysfunction in aging Taiwanese men.
    Liu CC; Lee YC; Tsai VF; Cheng KH; Wu WJ; Bao BY; Huang CN; Yeh HC; Tsai CC; Wang CJ; Huang SP
    Andrology; 2015 Sep; 3(5):902-8. PubMed ID: 26216079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?
    Francomano D; Greco EA; Lenzi A; Aversa A
    J Sex Med; 2013 Oct; 10(10):2373-81. PubMed ID: 23844628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
    Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
    J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
    Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.
    Tirabassi G; delli Muti N; Buldreghini E; Lenzi A; Balercia G
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):908-13. PubMed ID: 24787905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
    Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
    J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study.
    Stanworth RD; Akhtar S; Channer KS; Jones TH
    Eur J Endocrinol; 2014 Feb; 170(2):193-200. PubMed ID: 24165020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats.
    Huhtaniemi IT; Pye SR; Limer KL; Thomson W; O'Neill TW; Platt H; Payne D; John SL; Jiang M; Boonen S; Borghs H; Vanderschueren D; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC;
    J Clin Endocrinol Metab; 2009 Jan; 94(1):277-84. PubMed ID: 18840639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the CAG repeat androgen receptor polymorphism in andrology.
    Zitzmann M
    Front Horm Res; 2009; 37():52-61. PubMed ID: 19011288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
    Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
    J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism.
    Crabbe P; Bogaert V; De Bacquer D; Goemaere S; Zmierczak H; Kaufman JM
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3604-10. PubMed ID: 17579205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
    Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
    J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients.
    Zitzmann M; Depenbusch M; Gromoll J; Nieschlag E
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6208-17. PubMed ID: 15579779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of gonadotropin administration for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism and therapeutic measures.
    Giagulli VA; Triggiani V; Corona G; Carbone MD; Tafaro E; Licchelli B; Resta F; Sabbà C; Maggi M; Guastamacchia E
    Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):236-42. PubMed ID: 22385118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.